Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.65
Delayed Data
As of 12:15pm ET
 -0.04 / -2.37%
Today’s Change
1.39
Today|||52-Week Range
2.85
+12.63%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.69
Today’s open1.71
Day’s range1.65 - 1.75
Volume28,484
Average volume (3 months)39,686
Market cap$29.0M
Dividend yield--
Data as of 12:15pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)+17.60%
Earnings growth (this year)-66.37%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.21

Competitors

 Today’s
change
Today’s
% change
IMNPImmune Pharmaceutica...+0.00+2.10%
ANTHAnthera Pharmaceutic...-0.00-0.70%
MBRXMoleculin Biotech In...-0.20-8.66%
VKTXViking Therapeutics ...+0.04+2.92%
Data as of 12:54pm ET, 01/17/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts


Search for Jobs